These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12606237)

  • 1. Prion: toxic or infectious agent?
    Rico A
    Med Hypotheses; 2003 Feb; 60(2):209-14. PubMed ID: 12606237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental approaches to TSE prevention via inhibition of prion formation.
    Politopoulou G
    Protein Pept Lett; 2004 Jun; 11(3):249-55. PubMed ID: 15182226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human prion protein fragment 90-231, a useful model to study prion neurotoxicity.
    Corsaro A; Thellung S; Villa V; Nizzari M; Aceto A; Florio T
    OMICS; 2012; 16(1-2):50-9. PubMed ID: 22321015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host and transmissible spongiform encephalopathy agent strain control glycosylation of PrP.
    Somerville RA
    J Gen Virol; 1999 Jul; 80 ( Pt 7)():1865-1872. PubMed ID: 10423157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical Characterization of Prions.
    Fiorini M; Bongianni M; Monaco S; Zanusso G
    Prog Mol Biol Transl Sci; 2017; 150():389-407. PubMed ID: 28838671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Unconventional transmissible agents or prions].
    Dormont D
    Presse Med; 1997 Mar; 26(9):425-30. PubMed ID: 9137406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into prion strains and neurotoxicity.
    Aguzzi A; Heikenwalder M; Polymenidou M
    Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
    Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
    Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein misfolding cyclic amplification (PMCA): Current status and future directions.
    Saá P; Cervenakova L
    Virus Res; 2015 Sep; 207():47-61. PubMed ID: 25445341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prions and their partners in crime.
    Caughey B; Baron GS
    Nature; 2006 Oct; 443(7113):803-10. PubMed ID: 17051207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds?
    Caughey B; Caughey WS; Kocisko DA; Lee KS; Silveira JR; Morrey JD
    Acc Chem Res; 2006 Sep; 39(9):646-53. PubMed ID: 16981681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prion Concept and Synthetic Prions.
    Legname G; Moda F
    Prog Mol Biol Transl Sci; 2017; 150():147-156. PubMed ID: 28838659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion protein oligomer and its neurotoxicity.
    Huang P; Lian F; Wen Y; Guo C; Lin D
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):442-51. PubMed ID: 23557632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission and Replication of Prions.
    Marín-Moreno A; Fernández-Borges N; Espinosa JC; Andréoletti O; Torres JM
    Prog Mol Biol Transl Sci; 2017; 150():181-201. PubMed ID: 28838661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does an ultra violet photooxidation of the manganese-loaded/copper-depleted prion protein in the retina initiate the pathogenesis of TSE?
    Purdey M
    Med Hypotheses; 2001 Jul; 57(1):29-45. PubMed ID: 11421622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion protein conversions: insight into mechanisms, TSE transmission barriers and strains.
    Caughey B
    Br Med Bull; 2003; 66():109-20. PubMed ID: 14522853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.
    Miyazawa K; Okada H; Masujin K; Iwamaru Y; Yokoyama T
    Prion; 2015; 9(5):394-403. PubMed ID: 26555211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amphotericin B on wild-type and mutated prion proteins in cultured cells: putative mechanism of action in transmissible spongiform encephalopathies.
    Mangé A; Milhavet O; McMahon HE; Casanova D; Lehmann S
    J Neurochem; 2000 Feb; 74(2):754-62. PubMed ID: 10646527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.